Key result
Despite comprehensive therapy including surgery, radiotherapy, chemotherapy, and targeted therapies, the patient with laryngeal synovial sarcoma died of distant metastases.
Population
1 case of a 37-year-old man with primary laryngeal synovial sarcoma
Design
Case_report
Follow-up
41 months
Authors
Loading...
Despite multimodal therapy, laryngeal synovial sarcoma proved fatal via metastases; leaves open optimal strategies for this rare malignancy.
Case Report (n=1)
No
In a rare case of laryngeal synovial sarcoma, comprehensive therapy failed to prevent fatal metastasis, though PET/CT proved useful for detecting recurrence.
Bao et al. (2013) conducted a case report in Laryngeal synovial sarcoma (n=1). Comprehensive therapy (surgery, radiotherapy, chemotherapy, targeted therapy) was evaluated on Clinical outcome. Despite comprehensive therapy including surgery, radiotherapy, chemotherapy, and targeted therapies, the patient with laryngeal synovial sarcoma died of distant metastases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: